Showing results (1-10 of 131) with videos related to
Sort By:
Pageof 14
Osteoarthritis and Cartilage|September 18, 2021
Clinical monitoring in osteoarthritis: BiomarkersV B Kraus, M A KarsdalClimacteric : the Journal of the International Menopause Society|October 29, 2015
Role of biochemical markers in the management of osteoporosisK Henriksen, C Christiansen, M A KarsdalJournal of Thrombosis and Haemostasis : JTH|January 11, 2016
Collagen-mediated hemostasisT Manon-Jensen, N G Kjeld, M A KarsdalJournal of Neuromuscular Diseases|November 18, 2016
Neo-epitope Peptides as Biomarkers of Disease Progression for Muscular Dystrophies and Other MyopathiesA Arvanitidis, K Henriksen, M A Karsdal, et al.Climacteric : the Journal of the International Menopause Society|August 24, 2010
Strontium ranelate effect in postmenopausal women with different clinical levels of osteoarthritisP Alexandersen, M A Karsdal, I Byrjalsen, et al.Endocrine Reviews|September 21, 2010
Osteoclast activity and subtypes as a function of physiology and pathology--implications for future treatments of osteoporosisK Henriksen, J Bollerslev, V Everts, et al.DNA and Cell Biology|April 8, 2004
Matrix metalloproteinases (MMPs) safeguard osteoblasts from apoptosis during transdifferentiation into osteocytes: MT1-MMP maintains osteocyte viabilityM A Karsdal, T A Andersen, L Bonewald, et al.Drug News & Perspectives|January 5, 2006
The role of chloride channels in osteoclasts: ClC-7 as a target for osteoporosis treatmentS Schaller, K Henriksen, M G Sørensen, et al.Women'S Health (London, England)|November 2, 2011
Use of bone turnover markers in clinical osteoporosis assessment in women: current issues and future optionsK Henriksen, D J Leeming, C Christiansen, et al.Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|April 25, 2007
Biochemical markers in preclinical models of osteoporosisM G Sørensen, K Henriksen, S Schaller, et al.Pageof 14